An interventional study of Virtual reality exercise during hemodialysis in End Stage Renal Disease and Hemodialysis-Induced Symptom, sponsored by Cardenal Herrera University. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-17.
Sponsored by Cardenal Herrera University · Not applicable, Interventional, and Treatment
Among 68 studies in Kidney Failure, Chronic with a site in Spain — 10 open to participants now, 17 under way, 5 of them phase 3. Kidney Failure, Chronic · Spain.
Among the 68 studies in Kidney Failure, Chronic with a site in Spain, this one is the 44th largest by enrollment of the 55 interventional ones that give a count, is one of 5 that started in 2018, is one of 20 with no phase, and was the 34th registered.
2,108 studies on the registry are indexed under Kidney Failure, Chronic; 273 are open to participants now.
Browse Kidney Failure, Chronic studies →10 of the 68 studies in Kidney Failure, Chronic with a site in Spain are open now. Recruiting first, the newest first:
CSL Behring · Sites in Spain, United States, Argentina and 32 more countries
Hospital Universitari Vall d'Hebron Research Institute · Sites in Spain
UMC Utrecht · Sites in Spain, Italy, Netherlands
Oncorena AB · Sites in Spain, United States, France and 2 more countries
Hansa Biopharma AB · Sites in Spain, Finland, France and 3 more countries
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 170 Kidney Failure, Chronic studies recruiting now, 109 (64%) set no upper age limit and 32 (19%) stop at 75 or younger; 18 take children under 18; 22 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
68 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 14 · Phase 3 18 · Phase 4 4
First in 1994; this study’s year is marked. 5 started in 2018.
This study's enrollment of 40 is below the median of 57 across 1,569 interventional studies indexed under Kidney Failure, Chronic.
Median enrollment 120 across the 55 interventional studies, 356 across the 13 observational. Of the 45 that completed or were terminated, 17 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
42 of 68 have an industry lead sponsor. The 10 most frequent:
Cardenal Herrera University is the lead sponsor of 107 studies on the registry; 22 are open to participants now.
Cardenal Herrera University has 9 studies filed under Kidney Failure, Chronic — fewer than ten, so there is no comparison to draw.
5 of the studies in Kidney Failure, Chronic with a site in Spain that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04020055Phase 3Amicus TherapeuticsA Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease | 2026-12-31 |
| NCT03994471Phase 3Iperboreal Pharma SrlEfficacy and Safety of XyloCore Peritoneal Dialysis Solution. | 2026-12-31 |
| NCT05970172Phase 3Astellas Pharma Global Development, Inc.A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | 2027-10-30 |
| NCT05753930Hansa Biopharma ABImlifidase Prior to Kidney Transplant in Highly Sensitised Children | 2027-02-28 |
| NCT07607197Hospital Universitari Vall d'Hebron Research InstituteImmunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) | 2027-05 |
Among the 68 studies in Kidney Failure, Chronic with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The main objective of this investigation is to assess if an intradialysis virtual reality exercise-based program results in an improvement in physical function and if it results in high adherence rates to exercise. The secondary aim is to assess the effect of intradialysis VR in physical activity level, health related quality of life and in cognitive function.
Participants will be randomized into one of two groups. The first group will start with 12 weeks of virtual reality exercise during hemodialysis and will carry on with a control period of 12 weeks. The second group will start with a control period of 12 weeks (no exercise) and will carry on with a virtual reality exercise period of 12 weeks.
The virtual reality exercise will undertake up to 30 minutes of exercise. After warming up, participants will play to an adapted 'treasure hunt' game. Their legs movements will be the players projected into an individual tv that will give them feedback regarding their achievements. The aim of the game will be to achieve the higher possible score.They will move their legs to pick up coins and to avoid bombs. An adapted Kinect technology will be used for the game development. The exercise session will end-up with a cool-down period that will include simple lower limb stretching exercises.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
During 12 weeks subjects will exercise during hemodialysis. The intervention will be virtual reality exercise during hemodialysis.
Other: Virtual reality exercise during hemodialysis
During 12 weeks subjects will not exercise during hemodialysis
Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis treatment
Change from baseline gait speed at 12 weeks
Speed to cover 4 meters at normal speed
Time frame: Baseline, 12 weeks
Change from baseline sit to stand 10 at 12 weeks
Time to perform 10 sit to stand repetitions,
Time frame: Baseline, 12 weeks
Change from baseline sit to stand 60 at 12 weeks
Sit to stand repetitions performed in 60 seconds
Time frame: Baseline, 12 weeks
Change from baseline timed up and go at 12 weeks
Time to stand up, walk 3 meters, come back and sit down again
Time frame: Baseline, 12 weeks
Change from baseline short physical performance battery at 12 weeks
Score achieved at the battery that includes balance tests, sit to stand to sit 5 and and gait speed
Time frame: Baseline, 12 weeks
Change from baseline handgrip at 12 weeks
Bilateral handgrip strength
Time frame: Baseline, 12 weeks
Change from baseline one-leg standing test at 12 weeks
Time achieved while standing on one leg
Time frame: Baseline, 12 weeks
Change from baseline one-leg heel rise test at 12 weeks
Number of heel rise repetitions achieved
Time frame: Baseline, 12 weeks
Change from baseline 6 minutes walk test at 12 weeks
Number of meters walked in 6 minutes
Time frame: Baseline, 12 weeks
Change from baseline Physical activity level at 12 weeks
Physical activity questionnaires
Time frame: Baseline, 12 weeks
Change from baseline Health related quality of life at 12 weeks
Short Form 36 questionnaire to measure health-related quality of life
Time frame: Baseline, 12 weeks
Change from baseline Cognitive function at 12 weeks
Mini-mental State Examination questionnaire
Time frame: Baseline, 12 weeks
Adherence
Sessions performed/sessions offered
Time frame: 12 weeks
Healthcare resources expenditure and costs
Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation.
Time frame: 12 months before starting the exercise program- 12 months after the starting date
Plan to share: Undecided
Ran from Apr 2018 to primary completion in Sep 2018, 4 months.
Of 347 non-industry interventional studies with no phase under Kidney Failure, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 47. This study's 4 months is below that.
Counting every sponsor, half of 425 studies reached it within 23 months; a quarter within 8 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.